http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019189565-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3cd3ea6c52ef8544c67c051a2ef489b3
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61J1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4725
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-472
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5575
filingDate 2018-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0701d12464b26ceb9fd30c9e0361bfa6
publicationDate 2019-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2019189565-A
titleOfInvention Pharmaceutical formulation
abstract The present invention provides a pharmaceutical preparation containing an isoquinoline-6-amino derivative that is stable even at high temperatures. An aqueous composition containing (A) a compound of the following formula (including tautomers) or a salt thereof or a solvate thereof and (B) prostaglandins is contained in a transparent container. A pharmaceutical preparation. (R 1 and R 2 are each independently H or a C 1 -C 4 alkyl group; R 3 is H or OH; A is —CH (R 4 ) — or —CH 2 —CH (R 4 ) —; R 4 may have a substituent C 6 -C 10 aryl group, or an optionally substituted 5-10 membered heteroaryl group) [Selection figure] None
priorityDate 2018-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008154810-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0733650-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006249055-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018159700-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016515520-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018159701-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018159702-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44198631
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID13429
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414439679
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421898613
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID13429
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86270887

Total number of triples: 30.